AInvest Newsletter
Daily stocks & crypto headlines, free to your inbox
Date of Call: January 6, 2026
12% consumption growth and nearly 10% growth in net sales for Q1, contributing to overall company stability.Growth was driven by expanded distribution, marketing efforts, and recent product innovations.
Atkins Challenges and Strategic Adjustments:
19% decline in consumption, largely due to distribution losses at key retailers.The company is working with retailers to adjust the product assortment, focusing on repurposing space for more profitable SKUs from Quest and OWYN.
OWYN's Market Entry and Quality Improvements:
18%, supported by distribution gains in RTDs and powders.The company is addressing lingering product quality issues, with improved ratings and a new formula aimed at rebuilding consumer trust.
Financial Margins and Cost Management:
32.3% on a GAAP basis, reflecting higher input costs and tariff impacts.Initiatives such as pricing actions, cost-saving measures, and securing favorable supply commitments are aimed at improving margins in the second half of the fiscal year.
Share Buyback and Capital Allocation:
7% of its common stock, utilizing an incremental $150 million in borrowing.
Overall Tone: Positive
Contradiction Point 1
OWYN Product Quality Issue Status
This is a substantial contradiction regarding the resolution of a critical operational issue. The shift from declaring the issue is "largely resolved" to later stating its effects were still "lingering" and impacting inventory represents a material change in the narrative around product stability and supply chain health.
Could you clarify the path forward for OWYN, including recent brand performance, following the product quality issues that impacted the quarter? - Peter Grom (UBS)
2025Q4: The product issue... is largely resolved. The company has implemented a newer formulation, is shipping it, and has increased trade and marketing investments to recover. - Geoff Tanner(CEO)
Can you explain OWYN's inventory destocking progress this quarter? Is the gap narrowing in Q2, and will shipments match strong consumption? - Megan Christine Alexander (Morgan Stanley)
20260108-2026 Q1: The inventory gap was due to being heavy coming into Q1 (partly from an ERP cutover) and lingering effects from product quality issues. - Geoff Tanner(CEO)
Contradiction Point 2
Atkins Brand Strategy and SKU Rationalization
This is a substantial contradiction involving a clear change in company strategy. The shift from explicitly planning to reduce the Atkins brand footprint to stating a strong, long-term commitment to it, particularly for a key consumer segment (GLP-1), signals a significant strategic pivot that alters the competitive positioning and resource allocation narrative.
As fall 2025 resets approach, can you discuss performance, particularly regarding new innovation and your largest customer? - Megan Christine Alexander (Morgan Stanley)
2025Q2: Atkins is expected to have a slightly smaller footprint as the company shifts space to Quest/OWYN. - Geoff Tanner(CEO)
What steps are needed to reaccelerate growth in the legacy bar business—merchandising, rightsizing SKUs, or other strategies? - Brian Holland (D.A. Davidson)
20260108-2026 Q1: The brand remains committed long-term, especially for the GLP-1 consumer segment. - Geoff Tanner(CEO)
Contradiction Point 3
Gross Margin Trajectory and Timing
This is a substantial contradiction concerning the timing of a key financial benefit. The shift in guidance from expecting tariff benefits to flow through in the next fiscal year (FY26) to now stating they will start in the *second half* of the *current* fiscal year represents a delay in a material cost-saving headwind, directly impacting near-term margin forecasts.
Can you explain the change in the gross margin guide? You cited 100 bps from input costs/tariffs versus 150 bps previously, along with offsetting factors. What is driving this shift, and how clear is your visibility on input costs? - Megan Christine Alexander (Morgan Stanley)
2025Q2: Tariffs are estimated to be a $5-10M headwind for FY25... The significant benefits are expected in FY26 and are partially offset by higher inflation assumptions... - Shaun Mara(CFO)
When will tariff relief from new trade agreements take effect: this year's second half or fiscal 2027? - Matthew Smith (Stifel)
20260108-2026 Q1: Tariff benefits, including Annex 3 exemptions, will start to flow through in the second half of this fiscal year... - Christopher Bealer(CFO)
Contradiction Point 4
Atkins SKU Rationalization and Lower-Velocity SKUs
This is a substantial contradiction regarding market strategy and product portfolio management. The change in characterization from the sales decline being concentrated in "underperforming tail SKUs" (implying a broader issue) to explicitly labeling a significant portion of SKUs as "at risk" and part of a rationalization plan indicates a shift in how management is framing the brand's health and the scale of corrective action needed.
Is the 20% expected decline this year concentrated in lower-velocity SKUs and is there still pressure in the core? - Megan Christine Alexander (Morgan Stanley)
2025Q4: The majority of top-selling SKUs (representing 75% of Atkins sales) are growing healthily. The sales decline is concentrated in the underperforming tail SKUs... - Geoff Tanner(CEO)
What is the update on "tail" SKUs for Atkins and the process to reach an optimal assortment? - Jon Andersen (William Blair)
20260108-2026 Q1: For Atkins, 75% of sales come from SKUs in the top half of velocity (considered safe), while 10-15% are in the lowest quartile (at risk). The company is working with retailers to replace low-velocity Atkins SKUs... - Geoff Tanner(CEO)
Contradiction Point 5
OWYN's Growth Trajectory and Guidance
This is a substantial contradiction involving changes in the company's strategic narrative and confidence timeline for a key brand. The shift from stating the brand's deceleration was "fully anticipated" with clear confidence in a reacceleration "in the summer/fall" to a more tentative discussion of a "standard" relationship with "significant upside" but no specific timeline, represents a notable softening in the forward-looking tone and guidance precision for a critical growth driver.
Was the slowdown in OWYN's track data already factored into the guidance? Can you outline guardrails for OWYN's performance in fiscal 2026? - Peter K. Grom (UBS)
2025Q3: The OWYN deceleration in Q3 was fully anticipated and reflected in guidance... **Confidence remains high for OWYN's long-term growth, with distribution gains expected to reaccelerate in the summer/fall**. - Geoff E. Tanner(CEO)
How should we interpret the gap between OWYN's 4.5% household penetration and 20% aided brand awareness, and evaluate the increased marketing investment? - Brian Holland (D.A. Davidson)
20260108-2026 Q1: The relationship between aided awareness and household penetration is standard, but the low numbers indicate **significant upside opportunity**. The plan to accelerate growth includes increasing marketing (more than double)... - Geoff Tanner(CEO)
Discover what executives don't want to reveal in conference calls

Jan.10 2026

Jan.10 2026

Jan.09 2026

Jan.09 2026

Jan.09 2026
Daily stocks & crypto headlines, free to your inbox
Comments
No comments yet